PPARγ stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells

Neuroscience Letters

Volumn 454, Issue 2, 2009, Pages 134-138

  Miglio, Gianluca ^a   Rattazzi, Lorenza ^a   Rosa, Arianna C ^a   Fantozzi, Roberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Mitogen activated protein kinases; Neuronal differentiation; Pioglitazone; PPAR agonists

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; NEURITE; PHYSIOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURITES; NEUROGENESIS; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 62949132160     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.03.014     Document Type: Article

References (30)

1. Atwal J.K., Massie B., Miller F.D., and Kaplan D.R. The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron 27 (2000) 265-277
2. Berger J., and Moller D.E. The mechanisms of action of PPARs. Annu. Rev. Med. 53 (2002) 409-435
3. Biedler J.L., Roffler-Tarlov S., Schachner M., and Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38 (1978) 3751-3757
4. Braissant O., Foufelle F., Scotto C., Dauça M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 (1996) 354-366
5. Braissant O., and Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139 (1998) 2748-2754
6. Brodbeck J., Balestra M.E., Saunders A.M., Roses A.D., Mahley R.W., and Huang Y. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 1343-1346
7. Budde K., Neumayer H.H., Fritsche L., Sulowicz W., Stompôr T., and Eckland D. The pharmacokinetics of pioglitazone in patients with impaired renal function. Br. J. Clin. Pharmacol. 55 (2003) 368-374
8. Cimini A., Cristiano L., Benedetti E., D'Angelo B., and Cerù M.P. PPARs expression in adult mouse neural stem cells: modulation of PPARs during Astroglial Differentiation of NSC. PPAR Res. 2007 (2007) 48242
9. da Silva J.S., and Dotti C.G. Breaking the neuronal sphere: regulation of the actin cytoskeleton in neuritogenesis. Nat. Rev. Neurosci. 3 (2002) 694-704
10. Di Loreto S., D'Angelo B., D'Amico M.A., Benedetti E., Cristiano L., Cinque B., Cifone M.G., Cerù M.P., Festuccia C., and Cimini A. PPARbeta agonists trigger neuronal differentiation in the human neuroblastoma cell line SH-SY5Y. J. Cell. Physiol. 211 (2007) 837-847
11. Encinas M., Iglesias M., Llecha N., and Comella J.X. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem. 73 (1999) 1409-1421
12. Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Ceña V., Gallego C., and Comella J.X. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75 (2000) 991-1003
13. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 (1995) 803-812
14. Gardner O.S., Dewar B.J., and Graves L.M. Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling. Mol. Pharmacol. 68 (2005) 933-941
15. Goldberg J.L. How does an axon grow?. Genes Dev. 17 (2003) 941-958
16. Han S., Wada R.K., and Sidell N. Differentiation of human neuroblastoma by phenylacetate is mediated by peroxisome proliferator-activated receptor gamma. Cancer Res. 61 (2001) 3998-4002
17. Ivankovic-Dikic I., Grönroos E., Blaukat A., Barth B.U., and Dikic I. Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins. Nat. Cell Biol. 2 (2000) 574-581
18. Jung K.M., Park K.S., Oh J.H., Jung S.Y., Yang K.H., Song Y.S., Son D.J., Park Y.H., Yun Y.P., Lee M.K., Oh K.W., and Hong J.T. Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2. Mol. Pharmacol. 63 (2003) 607-616
19. Maeshiba Y., Kiyota Y., Yamashita K., Yoshimura Y., Motohashi M., and Tanayama S. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung 47 (1997) 29-35
20. McAllister A.K. Cellular and molecular mechanisms of dendrite growth. Cereb. Cortex 10 (2000) 963-973
21. Miloso M., Villa D., Crimi M., Galbiati S., Donzelli E., Nicolini G., and Tredici G. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J. Neurosci. Res. 75 (2004) 241-252
22. Moreno S., Farioli-Vecchioli S., and Cerù M.P. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123 (2004) 131-145
23. Pan J., Kao Y.L., Joshi S., Jeetendran S., Dipette D., and Singh U.S. Activation of Rac1 by phosphatidylinositol 3-kinase in vivo: role in activation of mitogen-activated protein kinase (MAPK) pathways and retinoic acid-induced neuronal differentiation of SH-SY5Y cells. J. Neurochem. 93 (2005) 571-583
24. Park K.S., Lee R.D., Kang S.K., Han S.Y., Park K.L., Yang K.H., Song Y.S., Park H.J., Lee Y.M., Yun Y.P., Oh K.W., Kim D.J., Yun Y.W., Hwang S.J., Lee S.E., and Hong J.T. Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. Exp. Cell Res. 297 (2004) 424-433
25. Radio N.M., and Mundy W.R. Developmental neurotoxicity testing in vitro: models for assessing chemical effects on neurite outgrowth. Neurotoxicology 29 (2008) 361-376
26. Satoh T., Furuta K., Suzuki M., and Watanabe Y. Prostaglandin J2 and its metabolites promote neurite outgrowth induced by nerve growth factor in PC12 cells. Biochem. Biophys. Res. Commun. 258 (1999) 50-53
27. Valentiner U., Carlsson M., Erttmann R., Hildebrandt H., and Schumacher U. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro. Toxicology 213 (2005) 157-168
28. Voss O.P., Milne S., Sharkey J., O'Neill M.J., and McCulloch J. Molecular mechanisms of neurite growth with AMPA receptor potentiation. Neuropharmacology 52 (2007) 590-597
29. Wada K., Nakajima A., Katayama K., Kudo C., Shibuya A., Kubota N., Terauchi Y., Tachibana M., Miyoshi H., Kamisaki Y., Mayumi T., Kadowaki T., and Blumberg R.S. Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J. Biol. Chem. 281 (2006) 12673-12681
30. Yki-Järvinen H. Thiazolidinediones. N. Engl. J. Med. 351 (2004) 1106-1118